Investors
Meet Our Valuable Investors
MOA & AOA
Memorandum & Articles of Association |
Details of Business
Details of Business |
Financial Results
FY 2021-2022 | Audited Standalone Financial Statements for 31.03.2022 | |
FY 2022 - 2023 | Audited Standalone Financial Statements for 31.03.2023 | |
Audited Consolidated Financial Statements for 31.03.2023 | ||
FY 2023-2024 | Audited Standalone and Consolidated Financial Results for quarter ended 30.06.2023 | |
Audited Standalone and Consolidated Financial Results for quarter ended 30.09.2023 | ||
Audited Standalone and Consolidated Financial Results for quarter ended 31.12.2023 | ||
Audited Standalone and Consolidated Financial Results for quarter and year ended 31.03.2024 | ||
FY 2024-2025 | Audited Standalone and Consolidated Financial Results for quarter ended 30.06.2024 | |
Audited Standalone and Consolidated Financial Results for quarter ended 30.09.2024 | ||
Audited Standalone and Consolidated Financial Results for the quarter ended 31.12.2024 | ||
Audited Standalone and Consolidated Financial Results for the quarter ended 31.03.2025 | ||
FY 2025-2026 | Audited Standalone and Consolidated Financial Results for the quarter ended 30.06.2025 |
Audited Financial Statements of Subsidiaries
FY 2022-2023 | Audited Standalone Financial Statements of Valiant Advanced Sciences Pvt Ltd for year ended 31.03.2023 | |
FY 2023-2024 | Audited Standalone Financial Statements of Valiant Advanced Sciences Pvt Ltd for quarter ended 30.06.2023 | |
Audited Standalone Financial Statements of Valiant Advanced Sciences Pvt Ltd for quarter ended 30.09.2023 | ||
Audited Standalone Financial Statements of Valiant Advanced Sciences Pvt Ltd for quarter ended 31.12.2023 | ||
Audited Standalone Financial Statements of Valiant Advanced Sciences Pvt Ltd for year ended 31.03.2024 | ||
FY 2024-2025 | Audited Standalone Financial Statements of Valiant Advanced Sciences Pvt Ltd for quarter ended 30.06.2024 | |
Audited Standalone Financial Statements of Valiant Advanced Sciences Pvt Ltd for quarter ended 30.09.2024 | ||
Audited Standalone Financial Statements of Valiant Advanced Sciences Pvt Ltd for quarter ended 31.12.2024 | ||
Audited Standalone Financial Statements of Valiant Advanced Sciences Pvt Ltd for quarter ended 31.03.2025 | ||
FY 2025-2026 | Audited Standalone Financial Statements of Valiant Advanced Sciences Pvt Ltd for quarter ended 30.06.2025 |
Annual Report
FY 2021-2022 | Annual Report 2022 | |
FY 2022-2023 | Annual Report 2023 | |
FY 2023-2024 | Annual Report 2024 | |
FY 2024-2025 | Annual Report 2025 |
Annual General Meetings
2023-24 | Newspaper Publication (Pre -AGM) | |
Newspaper Publication (Post AGM) | ||
Notice of Annual General Meeting | ||
AGM proceedings | ||
Scrutinizer's Report and Voting Results | ||
AGM Recording | ||
2024-25 | Newspaper Publication (Pre -AGM) | |
Letters to Shareholders | ||
Notice of the 4th AGM | ||
Newspaper Publication (Post AGM) |
Downloads
Form No. SH-14 | ||
Form ISR - 2 | ||
Form ISR - 1 | ||
Form ISR - 3 | ||
Form No. SH-13 | ||
Form ISR - 4 |
Contact Information
| Authorised Persons
Determining Materiality Pursuant to regulation 30(5) of the SEBI (Listing Obligation & Disclosure Requirements), Regulations 2015,the following are “severally” authorized for the purpose of determining materiality of an event or information and for the purpose of making disclosures to Stock Exchanges (s).
:
Mr. Santosh Vora (Managing Director) Mr. Paresh Shah (Executive Director & CFO) 104, Udyog Kshetra | First Floor, Mulund Goregaon Link Road, Mulund (W) – 400080 Disclosure Submission Mr. Akshay Gangurde 022 – 49712001 / 49717220 |
Shareholder Grievance and Nodal Officer
Pursuant to regulation 46(2) (j) (k) of the SEBI (Listing Obligation & Disclosure Requirements), Regulations 2015, the investors may contact the below mentioned email id for the purpose of Registering Complaints:
|
Registrar and Share Transfer Agent
Pursuant to Regulation 7 of the SEBI (Listing Obligation & Disclosure Requirements), Regulations 2015, the investors may contact the below mentioned Registrar and Share Transfer Agent: MUFG Intime India Pvt. Ltd.
(Formerly Known as Link Intime India Pvt. Ltd.) Unit: Valiant Laboratories Limited
C-101, 247 Park, L.B.S. Marg,
Vikhroli (West), Mumbai – 400 083 Phone: +91 22 4918 6000 Fax: +91 22 4918 6060 Email: rnt.helpdesk@in.mpms.mufg.com Website: www.in.mpms.mufg.com |